Heron Therapeutics (HRTX) Shares Issued (2016 - 2025)
Historic Shares Issued for Heron Therapeutics (HRTX) over the last 14 years, with Q3 2025 value amounting to $19.3 million.
- Heron Therapeutics' Shares Issued changed N/A to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year decrease of 3210.14%. This contributed to the annual value of $637000.0 for FY2024, which is 9785.92% down from last year.
- Latest data reveals that Heron Therapeutics reported Shares Issued of $19.3 million as of Q3 2025.
- In the past 5 years, Heron Therapeutics' Shares Issued registered a high of $74.4 million during Q3 2022, and its lowest value of -$18000.0 during Q4 2022.
- Over the past 5 years, Heron Therapeutics' median Shares Issued value was $764500.0 (recorded in 2021), while the average stood at $15.7 million.
- Per our database at Business Quant, Heron Therapeutics' Shares Issued skyrocketed by 7519.84% in 2021 and then tumbled by 10295.08% in 2022.
- Quarter analysis of 5 years shows Heron Therapeutics' Shares Issued stood at $610000.0 in 2021, then tumbled by 102.95% to -$18000.0 in 2022, then soared by 161494.44% to $29.1 million in 2023, then tumbled by 98.41% to $462000.0 in 2024, then surged by 4066.88% to $19.3 million in 2025.
- Its Shares Issued was $19.3 million in Q3 2025, compared to $462000.0 in Q4 2024 and $29.1 million in Q3 2023.